Global Burden of Disease Study - Tuberculosis
|
|
- Homer Richard
- 5 years ago
- Views:
Transcription
1 Global Burden of Disease Study - Tuberculosis An update Marieke J. van der Werf Marieke Geneva, J. van 9 der May Werf 2012 European Centre for Disease Prevention and Control Geneva 9 May 2012
2 Background The Global Burden of Diseases, Injuries, and Risk Factors 2010 Study (GBD 2010 Study) Started spring of 2007 Will produce estimates of the burden of - More than 220 conditions and injuries - More than 40 risk factors - For the years 1990, 2005, and For 21 regions - Improved methods for the estimation of health state severity weights 2
3 Collaborators Institute for Health Metrics and Evaluation (lead) Harvard University Johns Hopkins University University of Queensland World Health Organization (WHO) More than 800 researchers around the world 3
4 Plan Systematic reviews of incidence, prevalence, case fatality, and mortality for each disease and injury Generate all-cause and cause-specific mortality estimates for each age, sex and GBD Study region Perform internal consistency analysis using Dismod Revise analysis based on the feedback received through the peer review process Develop disability weights Produce final estimates of YLL, Causes of Death, and YLD for 1990, 2005, and 2010 and for each of the designated regions, and analyze trends 4
5 Tuberculosis estimates Strengths - Notification data available since Established methodology for estimating prevalence, incidence and mortality Weaknesses - No incidence studies in the general population - Limited number of prevalence studies in general population - Quality of vital registration data 5
6 Revising TB prevalence, incidence and mortality estimates Expert assessment of current methodology and identification of possibilities for improvement Review parameters HIV: abandon constant incidence rate ratio Systematic review for duration of disease Distribution of TB cases over age groups Systematic review of case fatality rates Proportion of culture positive among smear positives Abandon use of ARTI and Styblo rule Excel program Use more appropriate software 6
7 Systematic review: Duration of disease Studies from pre-chemotherapy area 2256 records assessed 16 studies included Case fatality rate in untreated smear-positive tuberculosis among HIV negative individuals is approximately 70% and about the same for both sexes The duration of tuberculosis from onset to cure or death is approximately 3 years and appears to be grossly similar for smear-positive and smear-negative tuberculosis Tiemersma EW, van der Werf MJ, Borgdorff MW, Williams BG, Nagelkerke NJ. Natural history of tuberculosis: duration and 7 fatality of untreated pulmonary tuberculosis in HIV negative patients: a systematic review. PLoS One Apr 4;6(4):e17601.
8 Systematic review: The effect of TB on mortality in people living with HIV Cohort studies comparing mortality in PLWH with and without TB 427 studies identified 15 included Hazard Ratio 1.8 (95% CI: ) Subanalysis of 8 studies in which the cohort was not exposed to HAART showed an HR of 2.6 (95% CI: ). Subanalysis of 6 studies in PLWH exposed to HAART: HR 1.1 (95% CI: ) Straetemans M, Bierrenbach AL, Nagelkerke N, Glaziou P, van der Werf MJ. The effect of tuberculosis on mortality in HIV positive people: a meta-analysis. PLoS One Dec 30;5(12):e
Assessing Tuberculosis Case Fatality Ratio: A Meta- Analysis
: A Meta- Analysis Masja Straetemans 1,2 *, Philippe Glaziou 3, Ana L. Bierrenbach 3, Charalambos Sismanidis 3, Marieke J. van der Werf 1,2 1 Unit Knowledge, Research and Policy, KNCV Tuberculosis Foundation,
More informationGBD2013 Tuberculosis estimates of mortality, incidence and prevalence
GBD2013 Tuberculosis estimates of mortality, incidence and prevalence Theo Vos Professor of Global Health March 31, 2015 Tuberculosis estimation strategy 1) Goal: Use all available data on different outcomes
More informationEstimates of TB incidence, prevalence and mortality. Philippe Glaziou Cairo, October 2009
Estimates of TB incidence, prevalence and mortality Philippe Glaziou Cairo, October 2009 Outline Main sources of information Incidence From incidence to prevalence From incidence to mortality TB/HIV MDR-TB
More informationLatest developments in WHO estimates of TB disease burden
Latest developments in WHO estimates of TB disease burden WHO Global Task Force on TB Impact Measurement meeting Glion, 1-4 May 2018 Philippe Glaziou, Katherine Floyd 1 Contents Introduction 3 1. Recommendations
More informationEpidemiology of tuberculosis in Europe. Marieke J. van der Werf European Centre for Disease Prevention and Control Amsterdam, 22 September 2014
Epidemiology of tuberculosis in Europe Marieke J. van der Werf European Centre for Disease Prevention and Control Amsterdam, 22 September 2014 Tuberculosis surveillance in the EU Aim: To provide a complete
More information1. TIME. TIME comprises two models:
1. TIME TIME comprises two models: TIME Estimates: This module is used for producing estimated and projected values for key TB indicators. These TB indicators include: TB incidence (particularly its split
More informationCORRELATES OF DELAYED INITIATION OF TREATMENT AFTER CONFIRMED DIAGNOSIS UNDER RNTCP: A CROSS SECTIONAL STUDY IN AHMEDABAD MUNICIPAL CORPORATION, INDIA
Original Article CORRELATES OF DELAYED INITIATION OF TREATMENT AFTER CONFIRMED DIAGNOSIS UNDER RNTCP: A CROSS SECTIONAL STUDY IN AHMEDABAD MUNICIPAL CORPORATION, INDIA Financial Support: None declared
More informationThe Scottish Burden of Disease Study, Diabetes technical overview
The Scottish Burden of Disease Study, 2016 Diabetes technical overview This resource may also be made available on request in the following formats: 0131 314 5300 nhs.healthscotland-alternativeformats@nhs.net
More informationTuberculosis management time: an alternative parameter for measuring the tuberculosis infectious pool
Tropical Medicine and International Health doi:10.1111/tmi.12246 volume 19 no 3 pp 313 320 march 2014 Tuberculosis management time: an alternative parameter for measuring the tuberculosis infectious pool
More informationGlobal Epidemiology of Tuberculosis
3 Philippe Glaziou, MD, MPhil 1 Dennis Falzon, MD, MSc 1 Katherine Floyd, MA, MSc, PhD 1 Mario Raviglione, MD 1 1 Stop TB Department (STB), HIV/AIDS, TB, Malaria and Neglected Tropical Diseases Cluster
More informationThe WHO END-TB Strategy
ENDING TB and MDR-TB The WHO END-TB Strategy Dr Mario RAVIGLIONE Director Joint GDI/GLI Partners Forum WHO Geneva, 27 April 2015 This talk will deal with TB Burden Progress, Challenges Way Forward Who
More informationEstimating TB burden. Philippe Glaziou World Health Organization Accra, Ghana
Estimating TB burden Philippe Glaziou World Health Organization Accra, Ghana Outline Basic facts about TB epidemiology What should we expect with regards TB burden over time? Main indicators of TB disease
More informationWHO Task Force Framework on assessment of TB surveillance data - Revisiting the "Onion model" Ana Bierrenbach WHO consultant Nov/Dec 2010
WHO Task Force Framework on assessment of TB surveillance data - Revisiting the "Onion model" Ana Bierrenbach WHO consultant Nov/Dec 2010 Task Force on TB Impact Measurement Mandate To produce a robust,
More informationTB Disease Prevalence Survey - Progress Report
TB Disease Prevalence Survey - Progress Report 30 Oct 2011, Lille Ikushi Onozaki MD, MPH Team Leader, TB Prevalence Survey WHO Global Task Force on TB Impact Measurement Stop TB Department, WHO onozakii@who.int
More informationThe epidemiology of tuberculosis
The epidemiology of tuberculosis Tuberculosis Workshop Shanghai, 12-22 May 28 Philippe Glaziou World Health Organization Outline Epidemiology refresher Estimates of tuberculosis disease burden Notifications
More informationPrinciple of Tuberculosis Control. CHIANG Chen-Yuan MD, MPH, DrPhilos
Principle of Tuberculosis Control CHIANG Chen-Yuan MD, MPH, DrPhilos Estimated global tuberculosis burden 2015 an estimated 10.4 million incident cases of TB (range, 8.7 million 12.2 million) 142 cases
More informationPerformance of RNTCP NTI Bulletin 2005,41/3&4,
Performance of RNTCP NTI Bulletin 2005,41/3&4, 118-122 A Cohort Analysis of Performance of RNTCP in MS Subramanya Rao*, KP Unnikrishnan**, MA Sharada BACKGROUND Tuberculosis (TB) is one of the most serious
More informationTB in the SEA Region. Review Plans and Progress. Dr Md Khurshid Alam Hyder Medical Officer TB SEARO/WHO
TB in the SEA Region Review Plans and Progress Dr Md Khurshid Alam Hyder Medical Officer TB SEARO/WHO The SEA Region: 25% of the world s people, but >33% of TB patients Eastern M editerranean Region 5%
More informationProgress towards tuberculosis elimination: secular trend, immigration and transmission
Eur Respir J 2010; 36: 339 347 DOI: 10.1183/09031936.00155409 CopyrightßERS 2010 Progress towards tuberculosis elimination: secular trend, immigration and transmission M.W. Borgdorff*,#, S. van den Hof
More informationEstimating the global burden of tuberculosis. WHO estimates of TB incidence, prevalence and mortality, by country,
Estimating the global burden of tuberculosis WHO estimates of TB incidence, prevalence and mortality, by country, 1990 2007 This morning s presentation Why estimate the burden? A brief history of TB estimates
More informationMeasuring progress in global tuberculosis control: WHO Policy and Recommendations DRAFT
Measuring progress in global tuberculosis control: WHO Policy and Recommendations DRAFT IMPORTANT NOTE: The main policies and recommendations are summarized on page 6 (synthesis of recommendations for
More informationWHO Library Cataloguing in Publication Data Assessing tuberculosis revalence through population-based surveys.
Assessing tuberculosis prevalence through population-based surveys WHO Library Cataloguing in Publication Data Assessing tuberculosis revalence through population-based surveys. 1. Tuberculosis, Pulmonary
More informationPrinciples of Writing a Paper and getting it published. Anthony D Harries The Union, Paris, France MSF, Brussels, Belgium
Principles of Writing a Paper and getting it published Anthony D Harries The Union, Paris, France MSF, Brussels, Belgium BASIC STRUCTURE Title Page Abstract Introduction, aim and objectives Methods (includes
More informationTuberculosis among public sector healthcare workers in ethekwini District, KwaZulu-Natal
ORIGINAL RESEARCH Tuberculosis among public sector healthcare workers in ethekwini District, KwaZulu-Natal S Mahomed 1, DR Khilawan 2, S Knight 2 1 School of Laboratory Medicine and Medical Science, College
More informationCMH Working Paper Series
CMH Working Paper Series Paper No. WG5 : 8 Title Interventions to reduce tuberculosis mortality and transmission in low and middle-income countries: effectiveness, cost-effectiveness, and constraints to
More informationCost Effectiveness of New Diagnostics for TB
Cost Effectiveness of New Diagnostics for TB David Bishai, Megan O Brien, David Dowdy Johns Hopkins University October 10, 2007 Outline Objectives What combinations of sensitivity and price would result
More informationThe Scottish Burden of Disease Study, Drug use disorders technical overview
The Scottish Burden of Disease Study, 2016 Drug use disorders technical overview This resource may also be made available on request in the following formats: 0131 314 5300 nhs.healthscotland-alternativeformats@nhs.net
More informationAppendix 3 Sample size and cost of surveys
Appendix 3 Sample size and cost of surveys Here we estimate the sample sizes needed to carry out prevalence of infection and disease, incidence of disease and verbal autopsy surveys in the 22 high burden
More informationScottish Burden of Disease Study, Rheumatoid arthritis technical overview
Scottish Burden of Disease Study, 2015 Rheumatoid arthritis technical overview This resource may also be made available on request in the following formats: 0131 314 5300 nhs.healthscotland-alternativeformats@nhs.net
More informationAnnex 1. Methods for evidence reviews and modelling
WHO/HTM/TB/2011.6a. Methods for evidence reviews and modelling Questions for the 2011 update of the Guidelines for the programmatic management of drug-resistant tuberculosis (for Outcomes please see Table
More informationThe role of ART and IPT in TB prevention: Latest updates
The role of ART and IPT in TB prevention: Latest updates Richard E. Chaisson, MD Center for Tuberculosis Research Johns Hopkins University Consortium to Respond Effectively To the AIDS-TB Epidemic (CREATE)
More information2006 Report. Tuberculosis Control. in the Western Pacific Region
IFC Report Tuberculosis Control in the Western Pacific Region Prepared by The Stop TB Unit in the WHO Regional Office for the Western Pacific Region, Dongil Ahn, Philippe Glaziou, Yao Hongyan, Pieter van
More informationMeasuring Progress Towards the Millennium Development Goals for TB Control
Measuring Progress Towards the Millennium Development Goals for TB Control Task Force convened under the auspices of the Strategic and Technical Advisory Group (STAG), Stop Tuberculosis Department, World
More informationIschaemic heart disease (IHD) is the leading
Ischaemic heart disease (IHD) is the leading cause of death in economically developed countries and is rapidly assuming serious dimensions in developing countries. It is expected to be the single most
More informationPrevalence of tuberculosis (TB) infection and disease among adolescents western Kenya: preparation for future TB vaccine trials
Prevalence of tuberculosis (TB) infection and disease among adolescents western Kenya: preparation for future TB vaccine trials Videlis Nduba 1,2, Peter Onyango 1, Anja Van t Hoog 1,3, Anthony Hawkridge
More informationChildren as Sentinels for Transmission and Policy Response Mercedes Becerra, ScD
Children as Sentinels for Transmission and Policy Response Mercedes Becerra, ScD Associate Professor, Harvard Medical School, Boston, MA, USA TB Specialist, Partners In Health, Boston, MA, USA Overview
More informationImproving the estimation of the tuberculosis burden in India
Krycia Cowling et al. Tuberculosis estimation in India This online first version has been peer-reviewed, accepted and edited, but not formatted and finalized with corrections from authors and proofreaders.
More informationThe Effect of Tuberculosis on Mortality in HIV Positive People: A Meta-Analysis
The Effect of Tuberculosis on Mortality in HIV Positive People: A Meta-Analysis Masja Straetemans 1,2 *, Ana L. Bierrenbach 3, Nico Nagelkerke 4, Philippe Glaziou 3, Marieke J. van der Werf 1,2 1 Unit
More informationRisk-Benefit Assessment of Foods. Maarten Nauta Research Group for Risk-Benefit
Risk-Benefit Assessment of Foods Maarten Nauta Research Group for Risk-Benefit What should I eat? IS ALL FOOD IS DANGEROUS? 2 3 Risk-Benefit Assessment Usually our research focus is on only risks or benefits
More informationGlobally, it is well documented that certain
Surveillance Report Characteristics and treatment outcomes of tuberculosis cases by risk groups, Japan, 2007 2010 Kazuhiro Uchimura, a Jintana Ngamvithayapong-Yanai, a Lisa Kawatsu, a Akihiro Ohkado, a
More informationMariza Vono Tancredi. Eliseu Alves Waldman
Mariza Vono Tancredi Eliseu Alves Waldman RATIONALE The clinical and laboratorial data from a population at a STD/AIDS Referral and Training Center (CRT) in Sao Paulo, Brazil, with 7,853 HIV infected individuals
More informationMultidrug-Resistant TB
Multidrug-Resistant TB Diagnosis Treatment Linking Diagnosis and Treatment Charles L. Daley, M.D. National Jewish Health University of Colorado Denver Disclosures Chair, Data Monitoring Committee for delamanid
More informationDefaulting from tuberculosis treatment in the Netherlands: rates, risk factors and trend in the period 1993±1997
Eur Respir J ; 16: 9±213 Printed in UK ± all rights reserved Copyright #ERS Journals Ltd European Respiratory Journal ISSN 93-1936 Defaulting from tuberculosis treatment in the Netherlands: rates, risk
More informationA household survey on screening practices of household contacts of smear positive tuberculosis patients in Vietnam
Thanh et al. BMC Public Health 2014, 14:713 RESEARCH ARTICLE Open Access A household survey on screening practices of household contacts of smear positive tuberculosis patients in Vietnam Thuy Hoang Thi
More informationThe Economic Cost of Non-adherence to TB Medicines Resulting from Stock-outs and Loss to Follow-up in Kenya
The Economic Cost of Non-adherence to TB Medicines Resulting from Stock-outs and Loss to Follow-up in Kenya March 2017 Photo Credit: Francis Nsanga UHMG, Photoshare, Kenya RESEARCH SUMMARY A key element
More informationPredicting outcomes and drug resistance with standardised treatment of active tuberculosis
Eur Respir J 21; 36: 87 877 DOI: 1.1183/931936.15179 CopyrightßERS 21 Predicting outcomes and drug resistance with standardised treatment of active tuberculosis O. Oxlade*,#, K. Schwartzman*,#, M. Pai*,#,
More informationBackground paper number 5
Background paper number 5 Assessing the quality and coverage of surveillance data in the UK: how is it done and how can HPA help to develop the Task Force framework for assessment of surveillance data,
More informationEstimates of Tuberculosis Mortality Rates in China Using the Disease Surveillance Point System, *
Biomed Environ Sci, 2012; 25(4): 483-488 483 Letters Estimates of Tuberculosis Mortality Rates in China Using the Disease Surveillance Point System, 2004-2010* ZHANG Hui"b.,HUANG Fei"b.,CHEN wei', DU Xin',
More informationThe Scottish Burden of Disease Study, Alcohol dependence technical overview
The Scottish Burden of Disease Study, 2016 Alcohol dependence technical overview This resource may also be made available on request in the following formats: 0131 314 5300 nhs.healthscotland-alternativeformats@nhs.net
More informationSame-day diagnosis of tuberculosis by microscopy. Policy statement
Same-day diagnosis of tuberculosis by microscopy Policy statement March 2010 Contents Abbreviations Executive summary 1. Background 2. Evidence for policy formulation 2.1 Synthesis of evidence 2.2 Management
More informationTuberculosis Screening and IPT: Experience from India
Tuberculosis Screening and IPT: Experience from India Dr B.B.Rewari WHO National consultant Care, Support and Treatment National Programme Officer (ART) National AIDS Control Organization New Delhi-110001,
More informationThe incubation period distribution of tuberculosis estimated with a molecular epidemiological approach
Published by Oxford University Press on behalf of the International Epidemiological Association ß The Author 2011; all rights reserved. Advance Access publication 26 March 2011 International Journal of
More informationAssessing spatial heterogeneity of MDR-TB in a high burden country
Assessing spatial heterogeneity of MDR-TB in a high burden country Appendix Helen E. Jenkins 1,2*, Valeriu Plesca 3, Anisoara Ciobanu 3, Valeriu Crudu 4, Irina Galusca 3, Viorel Soltan 4, Aliona Serbulenco
More informationPrinciples and Structure of a Research Protocol. Anthony D Harries The Union, Paris, France MSF, Brussels, Belgium
Principles and Structure of a Research Protocol Anthony D Harries The Union, Paris, France MSF, Brussels, Belgium BASIC STRUCTURE Background and rationale to study Aim and objectives (the research question)
More informationGeneric protocol for tuberculin school survey
Generic protocol for tuberculin school survey The generic protocol for tuberculin surveys is developed by KNCV Tuberculosis Foundation. This protocol has been based on the following documents: Guidelines
More informationRisk factors for active tuberculosis following antiretroviral treatment initiation in Abidjan
Risk factors for active tuberculosis following antiretroviral treatment initiation in Abidjan Catherine Seyler, Siaka Toure, Eugène Messou, Dominique Bonard, Delphine Gabillard, Xavier Anglaret Online
More informationSocioeconomic status and the 25x25 risk factors as determinants of premature mortality: a multicohort study of 1.7 million men and women
Socioeconomic status and the 25x25 risk factors as determinants of premature mortality: a multicohort study of 1.7 million men and women (Lancet. 2017 Mar 25;389(10075):1229-1237) 1 Silvia STRINGHINI Senior
More informationAntimicrobial Resistance in Typhoid: implications for policy & immunization strategies
Antimicrobial Resistance in Typhoid: implications for policy & immunization strategies Zulfiqar A Bhutta, Imran Ahmed, Daina Als, Amruta Radhakrishnan, Farah Qamar, Jeffrey Stanaway, Christopher Parry
More informationCOMMUNITY-BASED TBHIV CASE-FINDING KENYAN EXPERIENCE
COMMUNITY-BASED TBHIV CASE-FINDING KENYAN EXPERIENCE Exposing a hidden epidemic Kenya TB/HIV TEAM Introduction Population: 40 million 15 th among the 22 high TB burden countries 2012: TB case notification
More informationInvesting for Impact
Global Fund Strategic Framework: Investing for Impact M&E: Capturing data to improve services Workshop to Scale Up the Implementation of Collaborative TB/HIV Activities in Africa 10-11 April, 2013; Maputo,
More informationThe Global Burden of Foodborne Disease: Overview and Implications. Arie Havelaar on behalf of FERG
The Global Burden of Foodborne Disease: Overview and Implications Arie Havelaar on behalf of FERG Summary FERG: why, what, how? Global overview of burden of foodborne disease Regional differences Policy
More informationIntervention thematic group strategic portfolio
Intervention thematic group strategic portfolio Stakeholders meeting 31 st January 2013 White Sands Hotel intv@ihi.or.tz Description of the Thematic Group Focuses on human populations Individually and
More informationOverview of the Global Burden of Disease. December 3, 2015 Ali H. Mokdad, PhD Director, Middle Eastern Initiatives Professor, Global Health
Overview of the Global Burden of Disease December 3, 2015 Ali H. Mokdad, PhD Director, Middle Eastern Initiatives Professor, Global Health Outline 1) GBD 2013 2) Key results 3) US work 4) Recommendations
More informationStudy of Multi-Drug Resistance Associated with Anti-Tuberculosis Treatment by DOT Implementation Strategy in Pakistan
Journal of Basic & Applied Sciences, 2018, 14, 107-112 107 Study of Multi-Drug Resistance Associated with Anti-Tuberculosis Treatment by DOT Implementation Strategy in Pakistan Sana Saeed 1, Moosa Raza
More informationPost-2015 TB Elimination Strategy and Targets
Photo: Riccardo Venturi Vision and proposed framework for a Post-2015 TB Elimination Strategy and Targets Consultation on Eliminating the catastrophic economic burden of TB" Universal Health Coverage and
More informationMeasuring TB incidence, prevalence and mortality: an overview of the recommendations of the WHO Global Task Force on TB Impact Measurement
Measuring TB incidence, prevalence and mortality: an overview of the recommendations of the WHO Global Task Force on TB Impact Measurement Ana Bierrenbach WHO /STB / TME bierrenbacha@who.int Task Force
More informationChildhood Tuberculosis in the Kilimanjaro region: lessons from the TB Program
Childhood Tuberculosis in the Kilimanjaro region: lessons from the TB Program Charles M. Mtabho Gibson S. Kibiki Constantine F. Irongo Martin J. Boeree Rob E. Aarnoutse Introduction Tuberculosis (TB) remains
More informationXpert MTB/Rif What place for TB diagnosis in MSF projects? Francis Varaine, MSF Geneva, 29/11/10
Xpert MTB/Rif What place for TB diagnosis in MSF projects? Francis Varaine, MSF Geneva, 29/11/10 Introduction Excellent performances, rapid results, and easy to use Questions Where and how are we going
More informationNational Burden of Cancers Attributable to Secondhand Smoking in Indonesia
DOI:10.22034/APJCP.2018.19.7.1951 RESEARCH ARTICLE Editorial Process: Submission:02/26/2018 Acceptance:06/11/2018 National Burden of Cancers Attributable to Secondhand Smoking in Indonesia Ni Putu Ayu
More informationWHO Initiative to Estimate the Global Burden of Foodborne Diseases
International Food Safety Authorities Network (INFOSAN) 16 July 2008 INFOSAN Information Note No. 5/2008 WHO Initiative to Estimate the Global Burden of Foodborne Diseases WHO Initiative to Estimate the
More informationEnd TB Strategy top 10 indicators: current status in participant countries
End TB Strategy top 10 indicators: current status in participant countries Dennis FALZON Global TB Programme, WHO/HQ Geneva Regional WHO / Global Fund meeting Kenya 20 September 2016 Objectives of the
More information2010 global TB trends, goals How DOTS happens at country level - an exercise New strategies to address impediments Local challenges
Outline of what it will take Tuberculosis Elimination 25: Global and Local Challenges Anne Fanning, MD November 9, 211 21 global TB trends, goals How DOTS happens at country level - an exercise New strategies
More informationDM and TB Double Burden. Anil Kapur
DM and TB Double Burden Anil Kapur Association Between TB and DM Global Burden of DM and TB Diabetes Mellitus: 2011 Tuberculosis: 2011 [IDF Atlas 5 th Edition 2011] [WHO- Global TB Control 2012] 366 M
More informationExplanatory Notes. WHO Diabetes Country Profiles Background
Background WHO Diabetes Country Profiles 2016 WHO Diabetes Country Profiles 2016 Explanatory Notes In April 2016 the World Health Organization released the first Global report on diabetes. In conjunction
More information6/19/2014. Typhoid fever disease burden estimates. Methods: Revisiting the global burden of typhoid fever. Methodology- Ivanoff et al.
Typhoid fever disease burden estimates Methods: Revisiting the global burden of typhoid fever Dr. Vittal Mogasale, MBBS, MPH, PhD International Vaccine Institute Ivanoff et al. (1994): 16.6 million cases
More informationKatrina Frances Ortblad
Katrina Frances Ortblad Curriculum Vitae CONTACT 655 Huntington Ave Cell: 206-265-1856 Building 1, Room 1106A Email: katrina.ortblad@mail.harvard.edu Boston, MA 02215 Website: http://scholar.harvard.edu/kortblad
More informationTB Epidemiology. Richard E. Chaisson, MD Johns Hopkins University Center for Tuberculosis Research
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License. Your use of this material constitutes acceptance of that license and the conditions of use of materials on this
More informationNational TB Prevalence survey in Myanmar. By Dr. Thandar Lwin Programme Manager National TB Programme Department of Health
National TB Prevalence survey in Myanmar By Dr. Thandar Lwin Programme Manager National TB Programme Department of Health 58 million pop. 676,577 sq km (75/sq km) S+ notification rate/100,000 population
More informationOverview of the Presentation
Overview of the Presentation Definitions(TBCase, MDR-TB & XDR-TB) Global Tuberculosis (TB,HIV/TB,MDR & XDR)Scenario & Trend Risk factor for TB Natural history of TB Types of TB & Trends of Extra Pulmonary
More informationBenin Factsheets of Health Statistics 2010
Factsheets of Health Statistics 2010 Figure 1 : and neighboring countries Figure 2 : Population size (in thousands) in and neighboring countries, 2008 8,662 151,212 15,234 14,704 6,459 1. Health Status
More informationEthiopia. Factsheets of Health Statistics 2010
Factsheets of Health Statistics 2010 Novembre 2010 Figure 1 : and neighboring countries Figure 2 : Population size (in thousands) in and neighboring countries, 2008 80,713 41,348 38,765 8,926 4,927 849
More informationGuinea-Bissau. Factsheets of Health Statistics 2010
-Bissau Factsheets of Health Statistics 2010 Figure 1 : -Bissau and neighboring countries, 2008 -Bissau Figure 2 : Population size (in thousands) in -Bissau and neighboring countries, 2008 Bissau 1,575
More informationTUBERCULOSIS TREATMENT WITH MOBILE-PHONE MEDICATION REMINDERS IN NORTHERN THAILAND
Southeast Asian J Trop Med Public Health TUBERCULOSIS TREATMENT WITH MOBILE-PHONE MEDICATION REMINDERS IN NORTHERN THAILAND Piyada Kunawararak 1, Sathirakorn Pongpanich 2, Sakarin Chantawong 1, Pattana
More informationCongo. Factsheets of Health Statistics 2010
Factsheets of Health Statistics 2010 Figure 1 : and neighboring countries Democratic Republic of the Figure 2 : Population size (in thousands) in and neighboring countries, 2008 3,615 Democratic Republic
More informationQuestions and Answers Press conference - Press Centre Room 3 Wednesday 16 August 2006, 14.00hrs
Questions and Answers Press conference - Press Centre Room 3 Wednesday 16 August 2006, 14.00hrs What causes TB? TB is caused by the bacterium Mycobacterium tuberculosis. Although it can cause disease in
More informationApplication for inclusion, change or deletion of a medicine in the WHO Model List of Essential Medicines
Application for inclusion, change or deletion of a medicine in the WHO Model List of Essential Medicines We are a group of authors within an external affiliated non-government organisation, the Cochrane
More informationCôte d Ivoire Factsheets of Health Statistics 2010
Côte d Ivoire Factsheets of Health Statistics 2010 Figure 1 : Côte d Ivoire and neighboring countries Côte d Ivoire Figure 2 : Population size (in thousands) in Côte d Ivoire and neighboring countries,
More informationMozambique. Factsheets of Health Statistics 2010
Factsheets of Health Statistics 2010 Novembre 2010 Figure 1 : and neighboring countries Figure 2 : Population size (in thousands) in and neighboring countries, 2008 22,383 49,668 42,484 14,846 12,620 12,463
More informationSupplementary appendix
Supplementary appendix This appendix formed part of the original submission and has been peer reviewed. We post it as supplied by the authors. Supplement to: Stanaway JD, Flaxman AD, Naghavi M, et al.
More informationSerial Clinical Screening for Active Tuberculosis among HIV-infected Kenyan Adults
British Journal of Medicine & Medical Research 4(29): 4791-4801, 2014 SCIENCEDOMAIN international www.sciencedomain.org Serial Clinical Screening for Active Tuberculosis among HIV-infected Kenyan Adults
More informationCentral African Republic. Factsheets of Health Statistics 2010
Central African Republic Factsheets of Health Statistics 2010 Figure 1 : and neighboring countries Central African Republic Democratic Republic of the Figure 2 : Population size (in thousands) in and neighboring
More informationEpidemiology of Tuberculosis Denver TB Course
Epidemiology of Tuberculosis Denver TB Course Randall Reves, MD, MSc Volunteer Clinician Denver Metro TB Program and Division of Infectious Diseases, Department of Medicine University of Colorado Denver
More informationChad. Factsheets of Health Statistics 2010
Factsheets of Health Statistics 2010 Figure 1 : and neighboring countries ia Figure 2 : Population size (in thousands) in and neighboring countries, 2008 10,914 ia 151,212 41,348 19,088 14,704 Central
More informationIMPACT OF IMPROVED TREATMENT SUCCESS ON THE PREVALENCE OF TB IN A RURAL COMMUNITY BASED ON ACTIVE SURVEILLANCE
Original Article IMPACT OF IMPROVED TREATMENT SUCCESS ON THE PREVALENCE OF TB IN A RURAL COMMUNITY BASED ON ACTIVE SURVEILLANCE P. G. Gopi, R. Subramani, V. Chandrasekaran, T. Santha and P. R. Narayanan
More informationLesotho. Factsheets of Health Statistics 2010
Factsheets of Health Statistics 2010 Figure 1 : and neighboring countries Figure 2 : Population size (in thousands) in and neighboring countries, 2008 2,049 49,668 1,168 1. Health Status Life expectancy
More informationTuberculosis and BCG
Tuberculosis and BCG Steve Graham Centre for International Child Health University of Melbourne Department of Paediatrics Royal Children s Hospital Melbourne Child Lung Health International Union Against
More informationLet s Talk TB A Series on Tuberculosis, A Disease That Affects Over 2 Million Indians Every Year
A Series on Tuberculosis, A Disease That Affects Over 2 Million Indians Every Year Madhukar Pai, MD, PhD Author and Series Editor Camilla Rodrigues, MD co-author Abstract Most individuals who get exposed
More informationMali. Factsheets of Health Statistics 2010
Factsheets of Health Statistics 2010 Figure 1 : and neighboring countries Côte d Ivoire Figure 2 : Population size (in thousands) in and neighboring countries, 2008 12,706 34,373 20,591 15,234 14,704 12,211
More informationThe Lancet Infectious Diseases
Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study Susan E Dorman, Samuel G Schumacher, David Alland et al. 2017
More informationPopulation-Level Impact of Shorter-Course Regimens for Tuberculosis: A Model-Based Analysis
Population-Level Impact of Shorter-Course Regimens for Tuberculosis: A Model-Based Analysis Mariam O. Fofana 1,2 *, Gwenan M. Knight 3, Gabriela B. Gomez 4,5, Richard G. White 3, David W. Dowdy 1,6 * 1
More information